ENTO

Entero Therapeutics

16 hedge funds and large institutions have $6.69M invested in Entero Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$1.68M 695,504
JGC
2
J. Goldman & Co
New York
$1.4M 578,398 +27,040 +5%
GGHC
3
Gilder Gagnon Howe & Co
New York
$1.31M 541,536 +4,107 +0.8%
PCM
4
Parsons Capital Management
Rhode Island
$1.04M 431,283 -1,500 -0.3%
AAP
5
Ardsley Advisory Partners
Connecticut
$363K 150,000
Verition Fund Management
6
Verition Fund Management
Connecticut
$182K 75,000 +75,000 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$177K 73,321
WPW
8
Waldron Private Wealth
Pennsylvania
$169K 69,835 +69,835 New
TA
9
Tiedemann Advisors
New York
$145K 60,000
BlackRock
10
BlackRock
New York
$65K 26,850 -1,834 -6%
BFM
11
Boothbay Fund Management
New York
$55K 22,780
RC
12
RegentAtlantic Capital
New Jersey
$48K 20,000 +20,000 New
Northern Trust
13
Northern Trust
Illinois
$29K 12,075
PFGIA
14
Patriot Financial Group Insurance Agency
Massachusetts
$8K 3,100 +3,100 New
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$4K 1,500
Morgan Stanley
16
Morgan Stanley
New York
$3K 1,300
HCM
17
Highbridge Capital Management
New York
-131,456 Closed
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
-37,953 Closed
VF
19
Virtu Financial
New York
-10,113 Closed
UBS Group
20
UBS Group
Switzerland
-9,724 Closed
CFGS
21
Concourse Financial Group Securities
Alabama